An Australian biopharma company said Thursday that it has received approval to begin a series of clinical trials for its LSD microdosing drug designed as an aid to women’s health.
Vertex Pharmaceuticals unveiled VX-548, which showed positive results in three trials as developers continue to demonstrate its efficacy.
The U.K. NHS legalized medical cannabis five years ago, but a lack of government clinical trials has led Celadon Pharmaceuticals to pick up the slack.
Are “deuterated psilocybin analogs” the future of psychedelic therapy?
An Australian biopharma company said Thursday that it has received approval to begin a series of clinical trials for its LSD microdosing drug designed as an aid to women’s health.
Vertex Pharmaceuticals unveiled VX-548, which showed positive results in three trials as developers continue to demonstrate its efficacy.
The U.K. NHS legalized medical cannabis five years ago, but a lack of government clinical trials has led Celadon Pharmaceuticals to pick up the slack.
Are “deuterated psilocybin analogs” the future of psychedelic therapy?
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!